Fremont, CA, United States of America

Lynn Dixon

USPTO Granted Patents = 3 

Average Co-Inventor Count = 11.6

ph-index = 2

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lynn Dixon: Innovator in Analyte Monitoring Technology

Introduction

Lynn Dixon is a prominent inventor based in Fremont, CA (US), known for her contributions to the field of analyte monitoring technology. With a total of 3 patents to her name, she has made significant strides in developing devices and methods that enhance the management of diabetes and related conditions.

Latest Patents

One of her latest patents is a multi-function analyte monitor device and methods of use. This invention provides methods, systems, and devices for detecting an analyte sample, determining an analyte concentration associated with the detected analyte sample, and storing the determined analyte concentration along with a time associated with it. The technology allows for retrieving two or more stored analyte concentrations and determining an adjusted dose level based on current data. For instance, it can assist in adjusting dosage levels of long-acting insulin, which is crucial for effective diabetes management.

Another notable patent focuses on analyte monitoring devices, systems, and methods. This invention enables various application features on data processing devices for analyte monitoring, allowing for advanced programming and personalization of the devices. It also includes graphical representations of remaining insulin levels in a user's body and provides on-demand readings of analyte measurement data.

Career Highlights

Lynn Dixon is currently employed at Abbott Diabetes Care Inc., where she continues to innovate and develop technologies that improve patient care. Her work is instrumental in advancing the capabilities of analyte monitoring devices, making them more user-friendly and effective.

Collaborations

Throughout her career, Lynn has collaborated with notable colleagues, including Jonathan M. Fern and Mark P. Jesser. These partnerships have contributed to the successful development of her patented technologies.

Conclusion

Lynn Dixon's innovative work in analyte monitoring technology has made a significant impact on diabetes management. Her patents reflect her commitment to improving healthcare through advanced monitoring solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…